Imeshi Wijetunga

927 total citations
8 papers, 86 citations indexed

About

Imeshi Wijetunga is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Imeshi Wijetunga has authored 8 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Imeshi Wijetunga's work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Organ Donation and Transplantation (2 papers) and Vascular Malformations and Hemangiomas (2 papers). Imeshi Wijetunga is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Organ Donation and Transplantation (2 papers) and Vascular Malformations and Hemangiomas (2 papers). Imeshi Wijetunga collaborates with scholars based in United Kingdom. Imeshi Wijetunga's co-authors include G. Markides, Steven R. Brown, Rajendra Prasad, Nicola Ingram, P. Louise Coletta, Alexander F. Markham, Gemma Marston, Eldo T. Verghese, Judy Wyatt and Alex Markham and has published in prestigious journals such as Scientific Reports, American Journal of Transplantation and Cancers.

In The Last Decade

Imeshi Wijetunga

8 papers receiving 86 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Imeshi Wijetunga United Kingdom	6	55	39	14	13	12	8	86
Carlos Eduardo Mattos da Cunha Andrade Brazil	7	82 1.5×	22 0.6×	17 1.2×	14 1.1×	13 1.1×	18	139
Diego Odetto Argentina	6	42 0.8×	26 0.7×	11 0.8×	10 0.8×	11 0.9×	16	143
Sumner Kilmarx United States	3	48 0.9×	14 0.4×	7 0.5×	17 1.3×	12 1.0×	6	83
G. Xu China	5	57 1.0×	16 0.4×	10 0.7×	18 1.4×	24 2.0×	10	99
Gustavo Andreazza Laporte Brazil	5	23 0.4×	20 0.5×	10 0.7×	9 0.7×	10 0.8×	17	62
Naren Basu United Kingdom	6	50 0.9×	17 0.4×	5 0.4×	11 0.8×	18 1.5×	11	103
Sergi Fernández-González Spain	7	29 0.5×	15 0.4×	8 0.6×	12 0.9×	9 0.8×	17	84
Eugenio Morandi Italy	6	31 0.6×	39 1.0×	3 0.2×	20 1.5×	13 1.1×	13	93
M Lenhard Germany	6	26 0.5×	40 1.0×	6 0.4×	21 1.6×	5 0.4×	16	103
David Castenson United States	6	45 0.8×	90 2.3×	5 0.4×	8 0.6×	9 0.8×	7	121

Countries citing papers authored by Imeshi Wijetunga

Since Specialization

Citations

This map shows the geographic impact of Imeshi Wijetunga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imeshi Wijetunga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imeshi Wijetunga more than expected).

Fields of papers citing papers by Imeshi Wijetunga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imeshi Wijetunga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imeshi Wijetunga. The network helps show where Imeshi Wijetunga may publish in the future.

Co-authorship network of co-authors of Imeshi Wijetunga

This figure shows the co-authorship network connecting the top 25 collaborators of Imeshi Wijetunga. A scholar is included among the top collaborators of Imeshi Wijetunga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imeshi Wijetunga. Imeshi Wijetunga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Ingram, Nicola, Eldo T. Verghese, Imeshi Wijetunga, et al.. (2020). CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma. Cellular Oncology. 43(5). 835–845. 11 indexed citations

2.

Wijetunga, Imeshi, Agne Antanaviciute, Ian Carr, et al.. (2020). Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review. Cancers. 12(10). 2817–2817. 4 indexed citations

3.

Wijetunga, Imeshi, Nicola Ingram, Gemma Marston, et al.. (2019). Development of orthotopic tumour models using ultrasound-guided intrahepatic injection. Scientific Reports. 9(1). 9904–9904. 19 indexed citations

4.

Wijetunga, Imeshi, et al.. (2018). Bilateral adrenal hemorrhage in a neonatal kidney donor. Pediatric Transplantation. 22(4). e13173–e13173. 2 indexed citations

5.

Ingram, Nicola, Eldo T. Verghese, Imeshi Wijetunga, et al.. (2018). Neutrophil Gelatinase-associated Lipocalin as a Theragnostic Marker in Perihilar Cholangiocarcinoma. Anticancer Research. 38(12). 6737–6744. 7 indexed citations

6.

Wijetunga, Imeshi, et al.. (2018). Renal transplant from infant and neonatal donors is a feasible option for the treatment of end-stage renal disease but is associated with increased early graft loss. American Journal of Transplantation. 18(11). 2679–2688. 13 indexed citations

7.

Markides, G., et al.. (2015). Reversal of loop ileostomy under an Enhanced Recovery Programme – Is the stapled anastomosis technique still better than the handsewn technique?. International Journal of Surgery. 23(Pt A). 41–45. 7 indexed citations

8.

Markides, G., et al.. (2014). Meta‐analysis of handsewn versus stapled reversal of loop ileostomy. ANZ Journal of Surgery. 85(4). 217–224. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact